Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
Enregistré dans:
Auteurs principaux: | Anna M. De Kort, H. Bea Kuiperij, Daniel Alcolea, Iris Kersten, Alexandra A. M. Versleijen, Steven M. Greenberg, Erik Stoops, Floris H. B. M. Schreuder, Catharina J. M. Klijn, Alberto Lleó, Jurgen A. H. R. Claassen, Marcel M. Verbeek |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8bd655e7a32b48debbc472ad6cbb7185 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
par: Tainá M. Marques, et autres
Publié: (2021) -
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease
par: Zhen-Yi Andy Ou, et autres
Publié: (2021) -
COVID‐19‐associated thrombotic angiopathy improved after plasma exchange
par: Natalie Elkayam, et autres
Publié: (2021) -
Palinopsia as an initial symptom of cerebral amyloid angiopathy-related inflammation
par: Hitomi Onomura, et autres
Publié: (2021) -
Early MRI imaging and follow-up study in cerebral amyloid angiopathy
par: Zhang Shan-chun, et autres
Publié: (2021)